Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues US$ 23.01 Min. order: 1 piece ★★★★★ 4.4 (187 reviews) Sold : Login>>
Novo Nordisk shares higher on positive Phase 3 trial results for obesity drug Cagrilintide US$ 29.44 Min. order: 1 piece ★★★★★ 4.0 (223 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.21 Min. order: 1 piece ★★★★★ 4.0 (105 reviews) Sold : Login>>
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity US$ 20.11 Min. order: 1 piece ★★★★★ 4.8 (18 reviews) Sold : Login>>
BPC-157 5mg: High Purity Research Peptide for Studies US$ 21.50 Min. order: 1 piece ★★★★★ 4.3 (71 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 23.48 Min. order: 1 piece ★★★★★ 4.5 (202 reviews) Sold : Login>>